Ustekinumab in Pediatric Crohn Disease Patients.

Abstract excerpt

OBJECTIVES: We describe the use of ustekinumab for 4 patients with pediatric Crohn disease treated at the Seattle Children's Hospital Inflammatory Bowel Disease Center. METHODS: A retrospective chart review was done to identify patients' clinical data, disease phenotype, treatment history, and laboratory and growth parameters before treatment with ustekinumab and at last follow-up. Adverse events while on...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Adolescent
• Share to Antibodies, Monoclonal
• Share to C-Reactive Protein